Clinical trials, Yellow cards, Chemo brain, C...

We investigate how self-injecting is leading to people being hospitalised and is creating new challenges for support services.Laura Foster meets NHS endocrinologist Dr Bonnie Grant, criminologist at the University of Lincoln Dr Luke Turnock and Jon Findlay, Harm Reduction Lead at ...  Show more

We investigate the growing business of full-body MRI scans. The clinics argue they can spot diseases and problems early before people feel unwell - but critics say it’s a waste of thousands of pounds and creates unnecessary anxiety about things that may never become a problem. La ...  Show more

Why does one child become rebellious and another not? Claudia Hammond talks to Mark McDermott from the University of East London about new research into parenting and rebelliousness. She also hears from another shortlisted entry to the All in the Mind mental health awards. Plus, ...  Show more

JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ...

A new medication for psychosis is on the horizon. It's called KarXT and it could mean fewer side effects as well as finally some relief from difficulties with attention, concentration and memory - these are the symptoms patients often report as having the greatest impact on their ...  Show more